87588377 - LYMPHOQUANT

Information

• Trademark
• 87588377

• Source

• Serial Number

  87588377

• Registration Number

  6373233

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 29, 2017
  7 years ago

• Registration Date

  June 01, 2021
  3 years ago

• Transaction Date

  October 15, 2024
  6 months ago

• Status Date

  June 01, 2021
  3 years ago

• Published for Opposition Date

  January 30, 2018
  7 years ago

• Location Date

  April 27, 2021
  3 years ago

• First Use Anywhere Date

  September 08, 2019
  5 years ago

• First Use In Commerce Date

  September 08, 2019
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CLARK, ROBERT

• Attorney Docket Number

  62202-1020US

  Attorney Name

  Sarah W. Matthews

  Law Office Assigned Location Code

  L10

• Owners

  • INVIVOSCRIBE, INC
  • INVIVOSCRIBE TECHNOLOGIES, INC.

Case File Statements

• GS0051: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
• PM0001: LYMPH QUANT
• GS0011: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
• GS0441: DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
• GS0421: DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Case File Event Statements

• 9/1/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/6/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/4/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/5/2017 - 7 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/5/2017 - 7 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/5/2017 - 7 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/5/2017 - 7 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/10/2018 - 7 years ago

  10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/30/2018 - 7 years ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/30/2018 - 7 years ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/27/2018 - 7 years ago

  13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/28/2018 - 7 years ago

  14 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/28/2018 - 7 years ago

  15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 9/27/2018 - 6 years ago

  17 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/5/2017 - 7 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/26/2017 - 7 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 9/5/2018 - 6 years ago

  16 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 9/27/2018 - 6 years ago

  18 - SOU EXTENSION 1 FILED Type: EXT1

• 9/27/2018 - 6 years ago

  19 - SOU EXTENSION 1 GRANTED Type: EX1G

• 9/29/2018 - 6 years ago

  20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/21/2019 - 6 years ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/21/2019 - 6 years ago

  22 - SOU EXTENSION 2 FILED Type: EXT2

• 3/21/2019 - 6 years ago

  23 - SOU EXTENSION 2 GRANTED Type: EX2G

• 3/23/2019 - 6 years ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/26/2019 - 5 years ago

  25 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/26/2019 - 5 years ago

  26 - SOU EXTENSION 3 FILED Type: EXT3

• 9/26/2019 - 5 years ago

  27 - SOU EXTENSION 3 GRANTED Type: EX3G

• 3/25/2020 - 5 years ago

  29 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/25/2020 - 5 years ago

  30 - SOU EXTENSION 4 FILED Type: EXT4

• 3/25/2020 - 5 years ago

  31 - SOU EXTENSION 4 GRANTED Type: EX4G

• 3/27/2020 - 5 years ago

  32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/28/2019 - 5 years ago

  28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/24/2020 - 4 years ago

  33 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/24/2020 - 4 years ago

  35 - SOU EXTENSION 5 FILED Type: EXT5

• 9/30/2020 - 4 years ago

  34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/1/2020 - 4 years ago

  36 - SOU EXTENSION 5 GRANTED Type: EX5G

• 10/2/2020 - 4 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/25/2021 - 4 years ago

  40 - USE AMENDMENT FILED Type: IUAF

• 4/26/2021 - 3 years ago

  39 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 4/26/2021 - 3 years ago

  41 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 4/27/2021 - 3 years ago

  42 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 4/28/2021 - 3 years ago

  43 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 6/1/2021 - 3 years ago

  44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/10/2024 - 6 months ago

  46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/10/2024 - 6 months ago

  45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/10/2024 - 6 months ago

  47 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/25/2021 - 4 years ago

  38 - TEAS STATEMENT OF USE RECEIVED Type: EISU